Arnold M. Moses

3.8k total citations
106 papers, 2.6k citations indexed

About

Arnold M. Moses is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Social Psychology. According to data from OpenAlex, Arnold M. Moses has authored 106 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 31 papers in Molecular Biology and 21 papers in Social Psychology. Recurrent topics in Arnold M. Moses's work include Electrolyte and hormonal disorders (51 papers), Neuroendocrine regulation and behavior (21 papers) and Ion Transport and Channel Regulation (18 papers). Arnold M. Moses is often cited by papers focused on Electrolyte and hormonal disorders (51 papers), Neuroendocrine regulation and behavior (21 papers) and Ion Transport and Channel Regulation (18 papers). Arnold M. Moses collaborates with scholars based in United States, United Kingdom and Canada. Arnold M. Moses's co-authors include Myron Miller, Neil A. Breslau, David H. P. Streeten, Myron Miller, Ruth S. Weinstock, Michael A. Levine, Allen M. Spiegel, Steven J. Scheinman, Richard L. Coulson and Joan H. Howanitz and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Arnold M. Moses

99 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnold M. Moses United States 30 1.2k 1.0k 455 337 327 106 2.6k
C. R. Kleeman United States 27 570 0.5× 1.0k 1.0× 145 0.3× 195 0.6× 212 0.6× 71 2.4k
JP Bonjour Switzerland 20 324 0.3× 368 0.4× 177 0.4× 184 0.5× 133 0.4× 28 1.6k
J. Jones United Kingdom 21 601 0.5× 261 0.2× 169 0.4× 125 0.4× 182 0.6× 61 1.6k
Yasato Komatsu Japan 31 833 0.7× 1.6k 1.5× 537 1.2× 40 0.1× 468 1.4× 74 5.0k
C. J. Hillyard United Kingdom 27 150 0.1× 1.1k 1.1× 156 0.3× 218 0.6× 529 1.6× 47 3.4k
Thomas P. Jacobs United States 32 408 0.3× 665 0.6× 223 0.5× 42 0.1× 631 1.9× 50 3.5k
Cary W. Cooper United States 29 134 0.1× 978 0.9× 167 0.4× 86 0.3× 354 1.1× 113 2.7k
P. H. Baylis United Kingdom 26 845 0.7× 445 0.4× 142 0.3× 452 1.3× 161 0.5× 88 1.8k
A. G. H. Smals Netherlands 38 301 0.2× 685 0.7× 569 1.3× 99 0.3× 672 2.1× 156 4.1k
M. F. Scanlon United Kingdom 36 385 0.3× 760 0.7× 400 0.9× 91 0.3× 1.4k 4.3× 160 5.6k

Countries citing papers authored by Arnold M. Moses

Since Specialization
Citations

This map shows the geographic impact of Arnold M. Moses's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold M. Moses with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold M. Moses more than expected).

Fields of papers citing papers by Arnold M. Moses

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold M. Moses. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold M. Moses. The network helps show where Arnold M. Moses may publish in the future.

Co-authorship network of co-authors of Arnold M. Moses

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold M. Moses. A scholar is included among the top collaborators of Arnold M. Moses based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold M. Moses. Arnold M. Moses is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhaliwal, Ruban, et al.. (2014). Bone quality assessment in type 2 diabetes mellitus. Osteoporosis International. 25(7). 1969–1973. 145 indexed citations
2.
Kelly, Jenny, et al.. (2011). Orbital Inflammatory Disease in A Patient Treated with Zoledronate. Endocrine Practice. 17(4). e101–e103. 23 indexed citations
3.
Seton, Margaret, Arnold M. Moses, Rita Bode, & Carolyn E. Schwartz. (2010). Paget's disease of bone: The skeletal distribution, complications and quality of life as perceived by patients. Bone. 48(2). 281–285. 15 indexed citations
4.
Moses, Arnold M. & Richard Durbin. (2008). Inferring Selection on Amino Acid Preference in Protein Domains. Molecular Biology and Evolution. 26(3). 527–536. 9 indexed citations
5.
6.
Arekat, Mona R., et al.. (2002). Dramatic Improvement of BMD Following Vitamin D Therapy in a Bone Marrow Transplant Recipient. Journal of Clinical Densitometry. 5(3). 267–271. 9 indexed citations
7.
Buckler, Helen, William D. Fraser, D. J. Hosking, et al.. (1999). Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study. Bone. 24(5). 81S–85S. 35 indexed citations
8.
Doty, Richard L., et al.. (1997). Olfactory Dysfunction in Type I Pseudohypoparathyroidism: Dissociation from Gsα Protein Deficiency1. The Journal of Clinical Endocrinology & Metabolism. 82(1). 247–250. 18 indexed citations
9.
Moses, Arnold M., et al.. (1994). Acute Interstitial Nephritis With Renal Failure Associated With Propylthiouracil Therapy. American Journal of Kidney Diseases. 24(4). 575–577. 7 indexed citations
10.
Wenkert, David, John J. Merendino, Andrew Shenker, et al.. (1994). Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus. Human Molecular Genetics. 3(8). 1429–1430. 25 indexed citations
11.
Moses, Arnold M. & Steven J. Scheinman. (1993). Hereditary Vasopressin Resistance in Man and Mouse. Annals of the New York Academy of Sciences. 689(1). 233–249. 6 indexed citations
12.
Moses, Arnold M. & B. E. Clayton. (1993). Impairment of osmotically stimulated AVP release in patients with primary polydipsia. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 265(6). R1247–R1252. 20 indexed citations
13.
Moses, Arnold M., et al.. (1990). L-histidine augments the response to 1-deamino-8-D-arginine vasopressin in Brattleboro homozygous (di/di) rats.. Journal of Clinical Investigation. 85(3). 921–928.
14.
Weinstock, Ruth S. & Arnold M. Moses. (1990). Desmopressin and Indomethacin Therapy for Nephrogenic Diabetes Insipidus in Patients Receiving Lithium Carbonate. Southern Medical Journal. 83(12). 1475–1477. 22 indexed citations
15.
Moses, Arnold M., Jonathan Miller, & Michael A. Levine. (1988). Two Distinct Pathophysiological Mechanisms in Congenital Nephrogenic Diabetes Insipidus*. The Journal of Clinical Endocrinology & Metabolism. 66(6). 1259–1264. 14 indexed citations
16.
Moses, Arnold M., et al.. (1982). USE OF THE BRATTLEBORO RAT IN STUDIES OF THE MECHANISM BY WHICH CHLORPROPAMIDE ENHANCES THE ACTION OF VASOPRESSIN*. Annals of the New York Academy of Sciences. 394(1). 513–517. 2 indexed citations
17.
Moses, Arnold M., et al.. (1981). Antidiuretic Responses to Injected Desmopressin, Alone and with Indomethacin*. The Journal of Clinical Endocrinology & Metabolism. 52(5). 910–913. 10 indexed citations
18.
Gemert, Marcia van, et al.. (1974). Prolactin induced antidiuresis in the rat with diabetes insipidus. Federation Proceedings. 33. 5 indexed citations
19.
Moses, Arnold M., et al.. (1974). PITUITARY ADENOMA ASSOCIATED WITH INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION. European Journal of Endocrinology. 76(1). 59–66. 14 indexed citations
20.
Streeten, David H. P. & Arnold M. Moses. (1968). Action of Cortisol on Sodium Transport in Canine Erythrocytes. The Journal of General Physiology. 52(2). 346–362. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. R. Kleeman Breakdown of academic impact, for papers by JP Bonjour Breakdown of academic impact, for papers by J. Jones Breakdown of academic impact, for papers by Yasato Komatsu Breakdown of academic impact, for papers by C. J. Hillyard Breakdown of academic impact, for papers by Thomas P. Jacobs Breakdown of academic impact, for papers by Cary W. Cooper Breakdown of academic impact, for papers by P. H. Baylis Breakdown of academic impact, for papers by A. G. H. Smals Breakdown of academic impact, for papers by M. F. Scanlon
Rankless by CCL
2026